A pathophysiology diagram illustrating the metabolic pathway and cellular signaling of Vitamin A. The diagram is divided into three compartments: the bloodstream, the cytoplasm, and the nucleus. In the bloodstream, Retinol (ROH) is transported bound to Retinol-Binding Protein (RBP) and Transthyretin (TTR). Upon entering the cell, ROH binds to Cellular Retinol-Binding Protein (CRBP). It undergoes enzymatic oxidation via Retinol Dehydrogenase (RDH), Alcohol Dehydrogenase (ADH), or Short-chain Dehydrogenase/Reductases (SDR) to form Retinal (RAL). RAL is further oxidized by Aldehyde Dehydrogenase (ALDH) into All-Trans Retinoic Acid (ATRA). In the cytoplasm, ATRA binds to Cellular Retinoic Acid-Binding Protein (CRABP) or is catabolized by Cytochrome P450 into inactive metabolites (IM). Functionally, ATRA translocates to the nucleus where it binds to Retinoid X Receptor (RXR) and Retinoic Acid Receptor (RAR) complexes. This heterodimer binds to Retinoic Acid Response Elements (RARE) on DNA to regulate gene expression. The diagram uses standard abbreviations and includes a comprehensive legend for enzymes and transport proteins.

This composite educational figure illustrates the metabolic pathway and spatio-temporal dynamics of retinoic acid (RA) signaling during avian neural tube (NT) development across three stages: early neural crest (NC), advanced NC, and roof plate (RP). Panel A presents a schematic of RA metabolism, highlighting enzymes like RALDH/ALDH1 (synthesis) and CYP26A1 (degradation), carrier protein CRABP1, and the RARE-mediated transcriptional mechanism via RAR/RXR receptors. Panels B–M show in situ hybridization (ISH) results for key metabolic markers. Raldh2 transitions from paraxial mesoderm expression in early stages to strong localized expression in the nascent roof plate. Cyp1B1 remains restricted to the mesoderm. Cyp26A1 is detected in dorsal interneuron progenitors during advanced stages, while CRABP1 appears in lateral RP domains and differentiating neurons. Panels N–O' utilize fluorescence microscopy to visualize RA activity using a RARE-d2EGFP reporter. At both NC and RP stages, GFP signal (RA activity) is concentrated in the dorsal half of the neural tube, contrasted against an RFP control which shows ubiquitous transfection across the dorso-ventral axis. This visual evidence supports the role of local RA production in the transition from NC delamination to RP formation.

This composite figure illustrates the effect of retinoic acid receptor alpha b (RARαb) knockdown on retinal signaling and rod photoreceptor production in zebrafish embryos at 75 hours post-fertilization (hpf). Panels A and B are immunofluorescence images of RARE-YFP transgenic embryos. Panel A shows robust endogenous RA signaling (green YFP expression) in the ventral retina (bracketed), while Panel B demonstrates a marked reduction in signaling following injection of rarab/p53 morpholino (MO). Asterisks denote non-specific staining. Panels C and D show wildtype (SH) retinal sections labeled with 1D1 rod opsin antibody (red). Uninjected embryos (C) show normal rod distribution, whereas MO-injected embryos (D) exhibit a significant decrease in rod opsin expression. An arrowhead in C identifies the optic nerve head. Panel E is a bar graph quantifying these findings, showing that the average number of rods per section is significantly lower in the p53+rarab MO group (approximately 5 rods/section) compared to the uninjected control (approximately 11 rods/section), with statistical significance indicated by triple asterisks. Scale bar equals 50 μm.

This composite educational graphic illustrates the pathogenesis of Congenital Diaphragmatic Hernia (CDH) and the role of Retinoic Acid (RA) signaling. Panel (a) is an anatomical diagram showing a normal torso with an intact diaphragm separating the thoracic cavity (lungs, heart) from the abdominal cavity (liver, stomach, intestines). Panel (b) depicts CDH, where a diaphragmatic defect allows abdominal viscera to herniate into the chest, causing lung compression and mediastinal shift. Panel (c) is a clinical photograph of a dissected mouse fetal diaphragm (superior view) following teratogen exposure; an asterisk identifies a large, left-sided posterolateral (Bochdalek) defect. Panel (d) is a pathophysiology flowchart of the RA signaling pathway within the pleuroperitoneal fold (PPF). It details biochemical transitions from Retinol to Retinaldehyde and Retinoic Acid, mediated by enzymes like RDH10 and RALDH2. The diagram highlights key molecular components (STRA6, RARB, RXRA) where mutations or knockouts are linked to human CDH or rodent models, illustrating how disrupted gene expression in the PPF leads to structural diaphragmatic failure.

This composite figure illustrates the clinical and diagnostic progression of severe xerophthalmia and keratomalacia secondary to vitamin A deficiency in a 70-year-old male. Panels A, E, and G show clinical photographs highlighting characteristic Bitot's spots (foamy keratinized conjunctival plaques), corneal stromal infiltrates, and advanced keratomalacia with focal bulging (staphyloma formation). Panels B, D, F, H, and J utilize Anterior Segment Optical Coherence Tomography (AS-OCT) to quantify pathology, revealing conjunctival thickening (up to 737 μm), corneal stromal edema (1039 μm), and focal thinning (401 μm). Post-treatment panels (C, D, I, J) demonstrate clinical resolution after vitamin A supplementation and tectonic lamellar keratoplasty, with AS-OCT confirming successful graft adaptation. Histopathological sections (K, L) using HE and PAS stains contrast the diseased cornea against a normal control (M), showing massive epithelial hyperplasia (approximately 20 cell layers), focal keratinization, loss of Bowman's layer, and granular PAS-positive deposits, pathognomonic for squamous metaplasia in the setting of nutritional deficiency.

This clinical photograph demonstrates the oral administration of high-dose vitamin A supplementation to a pediatric patient. The image shows an adult health worker or caregiver using a manual technique to ensure safe delivery: one hand gently stabilizes the child's jaw and depresses the lower lip to keep the mouth open, while the other hand squeezes a small capsule or dispenser. A single, translucent red droplet of the liquid supplement is captured in mid-air, directed toward the child's open mouth. The child, appearing to be an infant or toddler, has their mouth open wide, revealing the tongue and primary dentition. This visual illustrates a common public health intervention used in nutritional programs to prevent vitamin A deficiency (VAD) and its associated complications, such as xerophthalmia and increased susceptibility to infections. The focus is on the practical application and administration technique within a community health or pediatric clinical setting.

A clinical photograph depicting the oral administration of a medical supplement, specifically Vitamin A, to a four-month-old infant. The infant is positioned supine, with the head slightly elevated and stable. A healthcare worker is shown using their thumb and index finger to gently depress the chin and retract the cheek, ensuring the mouth is sufficiently open for safe delivery. The administrator's other hand holds a small dropper or capsule, from which a single yellow liquid drop is descending into the infant's oral cavity. This visual illustrates a standard public health intervention in pediatrics, aimed at preventing xerophthalmia and reducing child morbidity and mortality associated with vitamin A deficiency in low-income regions. The procedure emphasizes safe manual handling and the technique for oral liquid dosing in infants who cannot yet swallow tablets or coordinate drinking from a cup.